Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum.

Dudhgaonkar S, Thyagarajan A, Sliva D.

Int Immunopharmacol. 2009 Oct;9(11):1272-80. doi: 10.1016/j.intimp.2009.07.011. Epub 2009 Aug 3.

PMID:
19651243
2.

Ganoderma lucidum: a potent pharmacological macrofungus.

Sanodiya BS, Thakur GS, Baghel RK, Prasad GB, Bisen PS.

Curr Pharm Biotechnol. 2009 Dec;10(8):717-42. Review.

PMID:
19939212
3.

Endogenous anti-inflammatory substances, inter-alpha-inhibitor and bikunin.

Kobayashi H.

Biol Chem. 2006 Dec;387(12):1545-9. Review.

PMID:
17132099
4.

Suppression of inflammatory and allergic responses by pharmacologically potent fungus Ganoderma lucidum.

Bhardwaj N, Katyal P, Sharma AK.

Recent Pat Inflamm Allergy Drug Discov. 2014;8(2):104-17. Review.

PMID:
24948193
5.

A comprehensive review of the structure elucidation and biological activity of triterpenoids from Ganoderma spp.

Xia Q, Zhang H, Sun X, Zhao H, Wu L, Zhu D, Yang G, Shao Y, Zhang X, Mao X, Zhang L, She G.

Molecules. 2014 Oct 30;19(11):17478-535. doi: 10.3390/molecules191117478. Review.

6.

Anti-inflammatory actions of pentacyclic triterpenes.

Safayhi H, Sailer ER.

Planta Med. 1997 Dec;63(6):487-93. Review.

PMID:
9434597
7.

The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis.

Weng CJ, Yen GC.

Clin Exp Metastasis. 2010 May;27(5):361-9. doi: 10.1007/s10585-010-9334-z. Epub 2010 May 12. Review.

PMID:
20461449
8.

Accessing biological actions of Ganoderma secondary metabolites by in silico profiling.

Grienke U, Kaserer T, Pfluger F, Mair CE, Langer T, Schuster D, Rollinger JM.

Phytochemistry. 2015 Jun;114:114-24. doi: 10.1016/j.phytochem.2014.10.010. Epub 2014 Nov 6. Review.

9.

Anticancer effects of Ganoderma lucidum: a review of scientific evidence.

Yuen JW, Gohel MD.

Nutr Cancer. 2005;53(1):11-7. Review.

PMID:
16351502
10.

Ganoderma lucidum for cancer treatment: we are close but still not there.

Cheng S, Sliva D.

Integr Cancer Ther. 2015 May;14(3):249-57. doi: 10.1177/1534735414568721. Epub 2015 Jan 27. Review.

PMID:
25626896
11.

Chemical constituents and pharmacological properties of Poria cocos.

RĂ­os JL.

Planta Med. 2011 May;77(7):681-91. doi: 10.1055/s-0030-1270823. Epub 2011 Feb 23. Review.

PMID:
21347995
12.

Biotechnological production and application of ganoderic acids.

Xu JW, Zhao W, Zhong JJ.

Appl Microbiol Biotechnol. 2010 Jun;87(2):457-66. doi: 10.1007/s00253-010-2576-5. Epub 2010 May 2. Review.

PMID:
20437236
13.

Longevity depends on a balance between proinflammatory and anti-inflammatory factors: use of TCMS and natural products.

Lien EJ, Lien LL, Wang J.

Curr Drug Discov Technol. 2010 Mar;7(1):13-21. Review.

PMID:
20156138

Supplemental Content

Support Center